Japanese encephalitis virus, Culex mosquitoes, brain inflammation, Asia and western Pacific risk, pigs, water birds, travel vaccine, diagnosis, and prevention

Japanese encephalitis

Japanese encephalitis is a mosquito-borne viral infection that is usually silent, but rare severe cases can inflame the brain and cause lasting neurologic injury.

Virus
Japanese encephalitis is caused by Japanese encephalitis virus, a flavivirus related to West Nile and dengue viruses.
Cycle
The virus circulates mainly between mosquitoes and vertebrate hosts such as wading birds and pigs.
Prevention
Mosquito-bite prevention is essential, and vaccination is recommended for some travelers and people in risk areas.
Japanese encephalitis virus circulates through mosquito and vertebrate-host cycles, with human cases usually occurring as spillover infections.View image on Wikimedia Commons

What Japanese encephalitis is

Japanese encephalitis is an infection caused by Japanese encephalitis virus. Most infections cause no symptoms or only mild illness, but a small share progress to encephalitis, which means inflammation of the brain. Severe disease can be life-threatening and can leave survivors with long-term neurologic needs.

Where it occurs

Japanese encephalitis occurs in parts of Asia and the western Pacific, especially where the virus, mosquito vectors, and amplifying hosts overlap. Risk is not the same everywhere or all year. Season, rainfall, irrigation, rural exposure, outdoor activity, lodging, and length of stay all shape a traveler's risk.

How the transmission cycle works

Culex mosquitoes can spread Japanese encephalitis virus after feeding on infected hosts. Wading birds help maintain the virus in nature, while pigs can amplify transmission near people. Humans usually do not develop enough virus in the blood to keep the cycle going, so human cases are typically spillover infections rather than the main engine of spread.

Symptoms

When illness develops, symptoms can include fever, headache, vomiting, confusion, weakness, movement problems, seizures, or coma. Children may have gastrointestinal symptoms or convulsions. Because early symptoms can look like other infections, travel and exposure history are important clues.

Diagnosis

Diagnosis usually combines neurologic symptoms, travel or residence in a risk area, and laboratory testing. Clinicians may test blood or cerebrospinal fluid for Japanese encephalitis virus-specific antibodies. Public-health laboratories can help confirm difficult cases, especially when related flaviviruses might complicate interpretation.

Treatment

There is no specific antiviral medicine for Japanese encephalitis. Treatment is supportive and may include hospital care, seizure control, breathing support, fluids, fever control, and management of brain swelling or complications. Rehabilitation can be important for people with lasting movement, speech, cognitive, or behavioral effects.

Vaccination and travel

Japanese encephalitis vaccine is used for people with meaningful exposure risk. In the United States, CDC recommends or considers vaccination based on destination, trip length, season, rural or outdoor activities, lodging, repeat travel, and uncertainty in the itinerary. Short urban trips outside transmission seasons often have very low risk, but travelers should discuss individual plans with a clinician.

Why it matters

Japanese encephalitis is rare for many travelers but serious when it occurs. In endemic areas, vaccination programs can sharply reduce disease burden, while mosquito control and rural health systems remain important. The disease shows how agriculture, ecosystems, travel, and vaccine policy intersect.

What public health teams watch

Surveillance looks for human encephalitis cases, mosquito activity, animal signals, seasonal patterns, and vaccination coverage. Teams also monitor traveler cases and changing risk areas. Climate, irrigation, land use, and movement of people and animals can all influence future transmission patterns.